All News
Who will be more likely to have chronic reactive arthritis @RheumNow #ACR20 @CRASCRRheum
Janet Pope Janetbirdope ( View Tweet)
IL-6 blockade for management of irAEs without inhibiting anti cancer immune response. Should these be given prior or concomitantly with ICIs? Some interesting ideas to look up from the cancer and immunotherapy study group. #ACR20 @UTSWNews @ACRheum @RheumNow
Adela Castro AdelaCastro222 ( View Tweet)
#ACR20 Abstr#0433 #PlenaryACR Georgia SLE registry 336 pts ⬆️stroke/isch heart dz with:
👉3X stroke risk and 24X IHD risk for black pts
👉predictors stroke: black race, DLE, renal dz
👉predictors IHD: age>65, black race, neuro & immuno d/o (e.g, APAs)
@RheumNow https://t.co/u6Ky7r0FYF
k dao KDAO2011 ( View Tweet)
Plenary session 1 no#2F011 #ACR20 @rheumnow
Black #SLE patients have a 3 fold higher stroke and 24 fold higher Ishemic Heart Disease risk! https://t.co/AYtiXk7pDa
Bella Mehta bella_mehta ( View Tweet)
Tech support during #ACR 20 per below if needed! @RheumNow https://t.co/6OIvJDJReq
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
Environmental and geographical factors matter! @rheumnow #ACR20 https://t.co/uq8236Dv5r
Bella Mehta bella_mehta ( View Tweet)
Dr. L Calabrese excellent review of irAEs and a proposed personalized algorithm for mgmt of irAE #ACR20 @LCalabreseDO @rheumnow
He believes there should be more studies combining TNFi or IL-6 with CPI https://t.co/GbvgXtNJnI
k dao KDAO2011 ( View Tweet)
Looking forward to learning lots in the next 20mins on how to approach #telemedicine to provide better care for our patients.
Important to remember to keep patients at the centre of our priorities.
#rheumtwitter
Session 2F05 #ACR20 @RheumNow https://t.co/aBrnytCWpu
Mrinalini Dey DrMiniDey ( View Tweet)
Behind the scenes at our #irae “study group” @NohaMDAnderson @LCalabreseDO #ACR20 #Immunotherapy https://t.co/eE7E7Qi1Zq
Cassandra Calabrese CCalabreseDO ( View Tweet)
Dr. Noha Abdel-wahab on timing for grade 3/4 irAE fastest with the skin after exposure to CPI #ACR20 @rheumnow https://t.co/sc5c6Zn3Uq
k dao KDAO2011 ( View Tweet)
#hydroxychloroquine is not a ‘cutie’ drug. E Park et al showed that HCQ does not increase QT interval in RA & SLE patients including if on other meds that may affect QT but known heart disease excluded from study #ACR20 #ACR2020 @RheumNow abstr#432 @CRASCRRheum https://t.co/FGVPknmj5q
Janet Pope Janetbirdope ( View Tweet)
#ACR20 Break time - go take a hike OR go ride a bike!
https://t.co/rYW3p4OgE3
Links:
Dr. John Cush RheumNow ( View Tweet)
@Rhemnow #ACR20 abs0307 analysis of PsA pts diagnostic pathway emphasizes difference in Dx coding by specialty (Derm unlikely to code arthritis, rheum unlikely to code PSO, PCP tend to code general MSK and axial symptoms). PSO and enthesitis codes increased closer to PsA Dx https://t.co/i6ZmjlD3xs
Olga Petryna DrPetryna ( View Tweet)
ACHILLES study: Only 56% of pts w/ clinical enthesitis had MRI+ heel enthesitis. MRI screening: HLAB27+ pts likely to be in MRI+ grp. @RheumNow #ACR20 Abstr#0447 #ACRbest https://t.co/m2cjDzYfyg
sheila RHEUMarampa ( View Tweet)
More UPA safety studies Abst#0215 shows balanced VTE event rates across UPA doses and comparator groups. Evidence for Dr. Strand to use in #ACR20 Great Debate that VTE may be safe TNF alternative @RheumNow. https://t.co/hByttIxiuX
Eric Dein ejdein1 ( View Tweet)
“Immunology is the cornerstone of medicine and we are the experts.” #ACR20 president, Dr. Ellen Gravallese @RheumNow
Dr. Rachel Tate uptoTate ( View Tweet)
Sustained DMARD-free remission (SFDR) seen in ACPA- RA pts; DAS levels at 4mos. predictive for SFDR. ACPA+ pts no relation w/ SFDR & DAS course @RheumNow #ACR20 Abstr#479 #ACRbest https://t.co/kko4tO7s1Y
sheila RHEUMarampa ( View Tweet)
Small study showed poor to fair agreement of PE and US findings of hands in PsA. Do you use US in your clinic for diagnostics? #ABS0314 @RheumNow #ACR20 https://t.co/6oQG4SB1d3 https://t.co/SQK7uhX02T
Dr. Rachel Tate uptoTate ( View Tweet)
JAKs are no longer new, Winthrop et al presents 8.4 year BARI data in Abst#0202 at #ACR20. VTE risk stable over time, again shows reason to vaccinate patients for zoster before starting. @RheumNow https://t.co/OSIvHl2f7Y
Eric Dein ejdein1 ( View Tweet)
Beautiful poster and fascinating research from @chriswincup et al showing immune cellular iron deficiency in patients with #SLE. Time to add iron supplementation as part of standard #lupus therapy?
https://t.co/Uf81KXbSM0
Abs#0294 #ACR20 @RheumNow https://t.co/z5SUjWFkdD
Mrinalini Dey DrMiniDey ( View Tweet)